ArticleScientific reports2025
Molecular epidemiological characteristics of coxsackievirus A6 in Jinhua, China, 2019-2023.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
We aimed to perform a retrospective analysis of the molecular epidemiological characteristics and genetic features of hand, foot and mouth disease (HFMD) associated with coxsackievirus A6 (CVA6) infections in Jinhua city from 2019 to 2023. Throat swab specimens were collected and tested. Two hundred CVA6-positive samples with viral loads>1 × [Formula: see text] copies/µL were randomly selected for VP1 sequence amplification and sequencing. Sequence analysis using sequencing analysis software. All methods were performed in accordance with the relevant guidelines and regulations. The number of HFMD cases fluctuated from 2019 to 2023.Children aged < 5 years accounted for the majority and boys were more frequently affected than girls. Genetic evolution analysis revealed that all 200 CVA6 strains belonged to subtype D3a and were on the D3a branch. Nucleotide homology and amino acid homology are somewhat different compared with representative strains in China and abroad. The full length of the CVA6 VP1 sequence was 915 bp, encoding 305 amino acids. Among the 200 prevalent strains in this study, 19 mutation sites were identified. Multiple transmission chains of CVA6 co-circulated in Jinhua City, exhibiting an enhanced virulence trend. There are multiple antigenic epitope amino acid variants in the VP1 gene.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.